Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pain × Dronabinol × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Cancer Pain 1

Interventions

Fentanyl 12 Zoledronic Acid 8 Ibandronic Acid 8 nabiximols 6 Tapentadol 5 Oxycodone 5 Morphine 4 Hydromorphone 4 alvimopan 3 Cryotherapy 3 Cryosurgery 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 resiniferatoxin 2 cabozantinib 2 Tetrodotoxin 2 Radiation 2 Prednisone 2 Naloxone 2 Diclofenac 2 Analgesics, Opioid 2 ziconotide 1 oxycodone naloxone combination 1 imisopasem manganese 1 fulranumab 1 Xylitol 1 Ultracet 1 Transdermal Patch 1 Therapeutics 1 Standard of Care 1 Rosuvastatin Calcium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00674609 2023-05-03

SPRAY

Jazz Pharmaceuticals

Phase 3 Completed

177 enrolled 21 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡